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Abstract 
Surgical resection for colorectal liver metastases may only be considered when an 
adequate functional residual volume can be preserved. Selective portal venous 
embolisation may be used to increase this volume, whilst chemotherapy and 
radiofrequency ablation (RFA) can be used to treat inoperable lesions. A 73-year-old man 
with liver metastasis proceeded to surgery, with the intention to perform a right 
hemi-hepatectomy. Unexpectedly at laparotomy, despite adequate pre-operative 
imaging, both the right and middle hepatic veins were involved. At that time extended 
right hemi-hepatectomy was contraindicated by insufficient residual volume and RFA 
was performed. Follow-up imaging revealed atrophy of the lesion. Significantly, there 
was also left lateral lobe hypertrophy sufficient to permit resection, which was 
performed without complication. Thrombosis of intra-hepatic portal veins is a 
recognised complication of RFA but here it appears to have been beneficial. The case 
highlights the need for regular review of unresectable hepatic disease by a liver surgeon 
and could suggest new modalities of portal embolisation. 
Introduction 
Surgical resection is the only proven curative treatment for colorectal liver metastases, 
resulting in overall 5-year survival rates of around 37% [1, 2]. Contraindications to 
resection include patient factors (co-morbidities precluding resection due to an 
unacceptably high operative risk) and tumour factors (presence of extensive extra-hepatic 
disease, including wide-spread local recurrence and extensive para-aortic  
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lymphadenopathy). For a resection to be considered, it must be technically possible to 
remove tumour completely while preserving an adequate functional residual liver volume. 
In recent years, the numbers of patients with colorectal metastases that are considered 
for hepatic resection have increased. Improvements in surgical techniques with an 
observed reduction in morbidity and mortality following resection have enabled a more 
aggressive surgical approach. New systemic chemotherapeutic agents such as oxaliplatin 
and irinotecan, and biological agents such as bevacizumab and cetuximab are also 
available, which in addition to treating in-transit disease also have an effect on established 
hepatic disease. In a proportion of individuals such treatment results in down-sizing of 
this hepatic disease, thus enabling them to be considered for resection [3]. When an 
extended hepatic resection is needed to clear disease that would leave insufficient residual 
liver volume, selective portal vein embolisation can be employed, which aims to increase 
the predicted functional residual volume, thus enabling a curative extensive resection [4]. 
Radiofrequency ablation (RFA) is the passage of electrical current through tissues 
to generate heat and cause cell death. Since its development in the late 1990s it has been 
used in the management of primary and secondary liver tumours, including colorectal 
liver metastases. Currently, RFA may be indicated if resection is not possible and the 
characteristics of the hepatic disease are favourable. Studies have shown a survival benefit 
of RFA compared with no treatment, but resection continues to be the gold standard, 
being the only modality offering long-term survival [2, 5, 6]. RFA is also used in 
combination with liver resection to treat amenable lesions in the residual liver that would 
otherwise preclude resection [7]. 
We report a case of colorectal liver metastasis in whom RFA appears to have facilitated 
a curative hepatic resection.  
Case Report 
A 69-year-old man was diagnosed with rectal cancer. Colonoscopy and computed tomography (CT) 
revealed no evidence of metastatic disease. Following anterior resection, histology confirmed a pT3 N2 
rectal adenocarcinoma. Post-operatively he received 6 months of adjuvant chemotherapy (fluorouracil 
[5-FU] and folinic acid). 
The patient remained symptom-free during follow-up, but 4 years later an elevated 
carcinoemobryonic antigen measurement was recorded (27 μg/l, normal range 0–10). CT and magnetic 
resonance imaging (MRI) revealed a lesion involving segments V and VIII of the right lobe of the liver, 
involving the right hepatic vein and close to the middle hepatic vein. There was no evidence of local or 
extra-hepatic recurrence on colonoscopy or positron emission tomography (PET) scan. 
He proceeded to surgery with intention to perform a right hepatectomy. Intra-operative ultrasound, 
however, revealed the tumour to involve both the right and middle hepatic veins. Tumour clearance 
would therefore have necessitated an extended right hepatectomy. As the hepatic parenchymal volume 
of the left lateral segment and the caudate lobe (the functional residual volume) was inadequate to 
permit an extended right hepatectomy, this procedure could not be performed. The lesion was therefore 
treated with RFA. 
His post-operative recovery was uneventful. Two weeks after surgery a CT scan confirmed that the 
RFA therapy had resulted in a large area of destruction in the right lobe of the liver. Adjuvant 
chemotherapy was commenced. Were the disease to remain static, right portal vein embolisation was to 
be considered, aiming to facilitate left lateral segment hypertrophy and permit an extended right 
hepatectomy.  
Case Rep Gastroenterol 2011;5:132–135 
DOI: 10.1159/000326959 
Published online: 
April 6, 2011 
© 2011 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
134
Follow-up cross-sectional imaging showed a 3 cm tumour around the previous RFA scar with 
tumour in segments V and VIII, extending into segments VI and I. The tumour had occluded the right 
hepatic vein and encased the origin of the middle hepatic vein, with extension up to the inferior vena 
cava, but the left hepatic and portal veins were spared. Full staging (PET and CT) showed no evidence of 
extra-hepatic disease. MRI also showed marked right lobe atrophy and unexpectedly, left lateral lobe 
hypertrophy (fig. 1). This lobar hypertrophy provided sufficient functional residual volume to render 
the lesion resectable. 
An extended right hemi-hepatectomy with excision of a cuff of inferior vena cava and a disc of 
diaphragm was carried out. Histology of the specimen revealed a completely excised metastatic 
adenocarcinoma consistent with colorectal origin. The patient made an uncomplicated recovery and 
returned to work 20 days after surgery. Five years following liver resection he is alive with several lung 
metastases which have responded to chemotherapy. His quality of life is excellent and at the age of 81 he 
is still running his own business. 
Discussion 
Despite adequate pre-operative imaging, intra-operative hepatic ultrasound assessment 
revealed this case of hepatic colorectal metastasis to be unresectable at that time. Extended 
right hepatectomy (right trisectionectomy), necessary to clear tumour involving the right 
and middle hepatic veins, would have left an inadequate functional residual volume. RFA 
was performed with the intention to ablate the tumour. Following recovery from surgery 
right portal vein embolisation was planned, with the intention to cause left lateral 
segment hepatic hypertrophy sufficient to permit resection. Follow-up cross-sectional 
imaging revealed surprising findings. In addition to tumour ablation, RFA seems to have 
caused right portal vein occlusion and consequent left lateral lobe hypertrophy. RFA 
alone appears to have inadvertently resulted in sufficient functional residual volume to 
permit an extended right hepatectomy. 
Portal vein (and arterial) thrombosis are known complications of RFA. Lesions near 
major vessels may not be heated uniformly due to the ‘heat sink’ effect of the blood flow. 
To abolish this effect, inflow occlusion – the Pringle manoeuvre – may be performed 
during the procedure. Experimental models and clinical experience have shown that RFA 
near the portal vein with inflow occlusion can result in thermal injury to the portal vein, 
thrombosis and deterioration of liver function. This effect was usually associated with 
inflow occlusion and cirrhosis [8, 9]. 
In most cases, inadvertent thrombosis of intra-hepatic portal veins would be a 
detrimental occurrence with potential for clot propagation, hepatic impairment and 
portal hypertension. In this case, thrombosis allowed for subsequent resection with 
curative intent. 
This case shows the scope of RFA in contributing to liver hypertrophy and also 
highlights the need for regular review by a liver surgeon in patients with liver tumours 
previously deemed unresectable. 
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Fig. 1. MRI scan after RFA. The tumour involves the vena cava and middle hepatic veins. The right 
hepatic vein is not seen. The right lobe of the liver shows atrophy and the left lateral lobe hypertrophy. 
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